Market Research Logo

Global Renal Anemia Therapeutics Market 2018-2022

Global Renal Anemia Therapeutics Market 2018-2022

About Renal Anemia Therapeutics

Anemia is a medical condition characterized by the body producing fewer red blood cells (RBCs)than normal, which results in a decline in oxygen delivery to vital tissues and organs. Renal anemia refers to anemia that occurs due to renal dysfunction or chronic kidney disease (CKD).

Technavio’s analysts forecast the global renal anemia therapeutics market to grow at a CAGR of 8.33% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global renal anemia therapeutics market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Renal Anemia Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AMAG Pharmaceuticals
  • AstraZeneca
  • Daiichi Sankyo
  • GlaxoSmithKline
  • PHARMACOSMOS
Market driver
  • Presence of large pool of CKD patients
  • For a full, detailed list, view our report
Market challenge
  • Side-effects of oral administration
  • For a full, detailed list, view our report
Market trend
  • Growing focus of vendors on emerging economies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CKD therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global – Market size and forecast 2017-2022 ($ mn)
      • Table Global – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by application
    • Segmentation by application
      • Table Application – Market share 2017-2022 (%)
    • Comparison by application
      • Table Comparison by application
    • IV – Market size and forecast 2017-2022
      • Table IV – Market size and forecast 2017-2022 ($ mn)
      • Table IV – Year-over-year growth 2018-2022 (%)
    • Oral – Market size and forecast 2017-2022
      • Table Oral – Market size and forecast 2017-2022 ($ mn)
      • Table Oral – Year-over-year growth 2018-2022 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Market segmentation by product
    • Segmentation by product
    • Epoetin alfa
    • Epoetin beta
    • Others
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Growing focus of vendors on emerging economies
    • Increasing instances of strategic collaborations among vendors
    • Rising number of drugs in pipeline
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AMAG Pharmaceuticals
      • Table AMAG Pharmaceuticals: Overview
      • Table AMAG Pharmaceuticals – Business segments
      • Table AMAG Pharmaceuticals – Organizational developments
      • Table AMAG Pharmaceuticals – Key offerings
    • AstraZeneca
      • Table AstraZeneca: Overview
      • Table AstraZeneca – Business segments
      • Table AstraZeneca – Organizational developments
      • Table AstraZeneca – Geographic focus
      • Table AstraZeneca – Key offerings
    • Daiichi Sankyo
      • Table Daiichi Sankyo: Overview
      • Table Daiichi Sankyo – Business segments
      • Table Daiichi Sankyo – Organizational developments
      • Table Daiichi Sankyo – Geographic focus
      • Table Daiichi Sankyo: Segment focus
      • Table Daiichi Sankyo – Key offerings
    • GlaxoSmithKline
      • Table GlaxoSmithKline: overview
      • Table GlaxoSmithKline – Business segments
      • Table GlaxoSmithKline – Organizational developments
      • Table GlaxoSmithKline – Geographic focus
      • Table GlaxoSmithKline – Segment focus
      • Table GlaxoSmithKline – Key offerings
    • PHARMACOSMOS
      • Table PHARMACOSMOS: Overview
      • Table PHARMACOSMOS – Business segment
      • Table PHARMACOSMOS – Organizational developments
      • Table PHARMACOSMOS – Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report